Evidence map›Paper›PMID 40480982›Full record

ArticleNature communications2025

Refining centromedian nucleus stimulation for generalized epilepsy with targeting and mechanistic insights from intraoperative electrophysiology.

Jonathan C Ho, Thandar Aung, Arianna Damiani, Lilly Tang, Arka N Mallela, Donald J Crammond, Jorge A González-Martínez

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jonathan C Ho *School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0009-0007-9463-6884
Thandar Aung *School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Arianna DamianiRehab and Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0009-0002-8521-865X
Lilly TangSchool of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Arka N MallelaDepartment of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-0993-198X
Donald J CrammondSchool of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Jorge A González-MartínezSchool of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. gonzalezjo@upmc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy affects 65 million people worldwide, with 30% suffering from drug-resistant epilepsy. While surgical resection is the primary treatment, its application is limited in generalized epilepsy. Centromedian nucleus neurostimulation offers a promising alternative, yet its mechanisms remain unclear, limiting target optimization. We present a multimodal approach integrating intraoperative thalamic and sub-scalp electroencephalogram recordings with post-implant reconstructions to define neural targets affected by centromedian nucleus stimulation. We find that stimulating low-activity regions near the centromedian nucleus, particularly the white matter of internal medullary lamina, induces significant cortical delta power increases greater than stimulation within high-activity areas inside the nucleus. Implantation in these low-activity targets results in greater than 50% seizure reduction in all three subjects. These findings suggest that seizure control primarily involves stimulating white matter regions such as the internal medullary lamina rather than the centromedian nucleus itself. A personalized, electrophysiology-guided implantation approach may enhance neurostimulation efficacy in drug-resistant epilepsy.

Indexed as

Deep Brain StimulationDrug Resistant EpilepsyEpilepsy, GeneralizedIntralaminar Thalamic NucleiAdultElectroencephalographyFemaleHumansMaleMiddle AgedTreatment OutcomeWhite MatterYoung Adult

Identifiers

PMID40480982
PMCPMC12144090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.